100
Participants
Start Date
February 20, 2025
Primary Completion Date
August 20, 2025
Study Completion Date
September 10, 2025
Finerenone
50 patients with biopsy proven glomerulonephritis who will receive 10 - 20 mg finerenone once daily orally in addition to their regular treatment protocol (RAAS blockers ± immunosuppression) for 6 months.
Placebo
50 patients with biopsy proven glomerulonephritis who will receive placebo once daily in addition to their regular treatment protocol (RAAS blockers ± immunosuppression) for 6 months.
RECRUITING
Faculty of Medicine, Aexandria University, Alexandria
Alexandria University
OTHER